Cancer Risk and Mutational Patterns Following Organ Transplantation
The rapid development of medical technology and widespread application of immunosuppressive drugs have improved the success rate of organ transplantation significantly. However, the use of immunosuppressive agents increases the frequency of malignancy greatly. With the prospect of “precision medicin...
Main Authors: | Yangyang Shen, Di Lian, Kai Shi, Yuefeng Gao, Xiaoxiang Hu, Kun Yu, Qian Zhao, Chungang Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.956334/full |
Similar Items
-
Liver Transplantation for Unresectable Intrahepatic Cholangiocarcinoma: The Role of Sequencing Genetic Profiling
by: Salvatore Gruttadauria, et al.
Published: (2021-12-01) -
Clinical characteristics and treatment strategy of nocardiosis in lung transplant recipients: A single-center experience
by: Yu Xu, et al.
Published: (2023-01-01) -
Comprehensive analyses of genomic features and mutational signatures in adenosquamous carcinoma of the lung
by: Hongbiao Wang, et al.
Published: (2022-09-01) -
TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell Transplantation
by: Davidson Zhao, et al.
Published: (2023-06-01) -
Alterations of lung microbiota in lung transplant recipients with pneumocystis jirovecii pneumonia
by: Qiaoyan Lian, et al.
Published: (2024-03-01)